Neurocrine Biosciences (NBIX) Current Deferred Revenue (2010 - 2013)
Neurocrine Biosciences' Current Deferred Revenue was $730,000 in Q3 2013, down 92.8% from $10.18 million a year earlier and down 50.0% from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Current Deferred Revenue (2010 - 2013) Analysis & Trends
At the end of FY2012, Current Deferred Revenue at Neurocrine Biosciences came in at $2.92 million, down 91.5% from FY2011.
- In earlier years, Current Deferred Revenue was $34.24 million in FY2011 (-7.5%) and $37.03 million in FY2010.
- The Q3 2013 figure marks the lowest quarterly Current Deferred Revenue in data going back to Q4 2010.
- Compared with a year earlier, Current Deferred Revenue has declined for six straight quarters, with an average decline of 71.3% over the last seven quarters.
- Per Business Quant data, NBIX's Current Deferred Revenue in the three quarters before Q3 2013 was $1.46 million (Q2 2013), $2.19 million (Q1 2013) and $2.92 million (Q4 2012).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Neurocrine Biosciences | 14.41 Bn | 10.11 Bn | 935.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2013 | 730,000.00 |
| Jun 30, 2013 | 1.46 Mn |
| Mar 31, 2013 | 2.19 Mn |
| Dec 31, 2012 | 2.92 Mn |
| Sep 30, 2012 | 10.18 Mn |
| Jun 30, 2012 | 17.44 Mn |
| Mar 31, 2012 | 25.74 Mn |
| Dec 31, 2011 | 34.24 Mn |
| Sep 30, 2011 | 35.49 Mn |
| Jun 30, 2011 | 36.74 Mn |
| Dec 31, 2010 | 37.03 Mn |
API Access
Neurocrine Biosciences Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();